Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for SITAGLIPTIN

Ingredient

SITAGLIPTIN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
SANDOZ SITAGLIPTIN-METFORMIN XR	50MG 500MG	TABLET (EXTENDED-RELEASE)	Resolved	2025-09-29	2025-10-04	268030
SANDOZ SITAGLIPTIN-METFORMIN XR	500MG 50MG	TABLET (EXTENDED-RELEASE)	Resolved	2024-07-15	2024-08-21	232912
TARO-SITAGLIPTIN FUMARATE	25MG	TABLET	Resolved	2024-09-11	2025-04-04	237254
TARO-SITAGLIPTIN FUMARATE	50MG	TABLET	Resolved	2024-09-11	2025-01-27	237257
TARO-SITAGLIPTIN FUMARATE	100MG	TABLET	Resolved	2024-09-11	2025-02-10	237260
TEVA-SITAGLIPTIN MALATE	25MG	TABLET	Actual shortage	2025-03-06	2025-12-12	252059
TEVA-SITAGLIPTIN MALATE	100MG	TABLET	Actual shortage	2025-03-06	2025-12-12	252066
TEVA-SITAGLIPTIN MALATE	50MG	TABLET	Actual shortage	2025-03-06	2025-12-12	252062

Previous
1
…
8
9
10

Showing 91 to 98 of 98

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
JANUMET	850MG 50MG	TABLET	Discontinued	2024-12-12	2025-08-14	245516
STEGLUJAN	5MG 100MG	TABLET	Discontinued	2021-02-04	2021-02-04	133310
STEGLUJAN	15MG 100MG	TABLET	Discontinued	2021-02-04	2021-02-04	133307

1

Showing 1 to 3 of 3